查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927702

全球阿茲海默症診斷市場按類型、診斷技術、最終用戶、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032年）

Alzheimer's Disease Diagnostics Market, Report By Type, By Diagnostic Technique, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 382 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年阿茲海默症診斷市場規模價值為 921.901 億美元，從 2025 年到 2032 年的複合年成長率為 11.19%。

由於神經退化性疾病盛行率不斷上升、人口老化以及人們對早期診斷意識的增強，全球阿茲海默症診斷市場正穩步成長。基於生物標記的檢測、神經影像學和血液診斷等技術的進步提高了檢測準確率，從而能夠更早地進行干預。政府的支持性政策、不斷增加的研究經費以及診斷服務的普及，進一步推動了已開發經濟體和新興經濟體的市場成長。

阿茲海默症診斷市場—市場動態

阿茲海默症率上升與人口老化

全球人口老化和阿茲海默症發病率上升是推動先進診斷解決方案需求的主要因素。早期準確診斷對於有效疾病管理、制定合適的治療方案以及提高患者生活品質至關重要。例如，根據歐洲腦理事會2025年1月發布的報告，目前歐洲約有700萬人患有阿茲海默症，預計到2030年，由於人口老化，這一數字將增加至約1,400萬。這凸顯了該疾病日益加重的公共衛生負擔。診斷技術的進步，包括基於生物標記的檢測和非侵入性神經影像技術，以及醫療專業人員意識提升的提高，正在加速診斷方法的應用。同時，診斷設備製造商持續加大研發投入，正在強化產品平臺，並推動全球診斷能力的提升。

阿茲海默症診斷市場—市場細分分析：

全球阿茲海默症診斷市場按類型、診斷技術、最終用戶和地區進行細分。

按類型分類，阿茲海默症可分為早發性阿茲海默症和晚發性阿茲海默症。由於晚發性阿茲海默症在老年人中發病率較高，因此佔據了市場的大部分佔有率。此外，全球老年人口的成長和預期壽命的延長也顯著促進了晚發性阿茲海默症病例的增加。老年人診斷意識的提高和醫療保健利用率的上升進一步鞏固了該細分市場的主導地位。

依診斷技術分類，市場可分為神經影像學、生物標記檢測、基因檢測、認知功能檢測和其他診斷方法。神經影像學和基於生物標記的診斷方法因其診斷準確率高且在臨床應用中日益普及，佔據了較大的市場佔有率。影像技術的進步和生物標記的發現使得阿茲海默症的早期可靠檢測成為可能。此外，精準醫療投入的增加以及這些技術在臨床試驗中的應用，也推動了其廣泛普及。

依最終用戶分類，市場可分為醫院/診所、診斷檢查室、研究機構和其他機構。醫院和診斷檢查室憑藉其龐大的患者數量和先進的診斷基礎設施，佔據市場主導地位。這些機構也受益於熟練的醫療專業人員和綜合診斷服務，從而能夠及時準確地檢測出疾病。此外，醫院篩檢計畫的增加和病患轉診量的上升進一步鞏固了其市場主導地位。

阿茲海默症診斷市場—區域洞察

北美在阿茲海默症診斷市場佔據主導地位，這主要歸功於其先進的醫療基礎設施、較高的公眾認知度以及創新診斷技術的快速普及。這些因素有助於早期發現和及時干預，在有效管理阿茲海默症方面發揮著至關重要的作用。歐洲緊隨其後，這得益於其完善的研究設施和鼓勵投資新型診斷方法和技術的政府醫療政策。在亞太地區，人口老化顯著加劇，加上醫療服務可近性的提高以及對診斷基礎設施投資的增加（尤其是在中國和印度等主要市場），預計將推動市場快速成長。這些國家正優先加強其醫療體系，以應對日益成長的阿茲海默症率。同時，由於大眾對阿茲海默症的認知度提高以及診斷能力的進步，拉丁美洲和中東及非洲預計將實現溫和成長。這有望最終改善這些地區的患者管理和治療效果。

阿茲海默症診斷市場—國家/地區洞察

美國在阿茲海默症診斷市場保持主導地位。這得益於美國診斷測試的高利用率、健全的健保體系（使患者能夠獲得最尖端科技）以及眾多推動創新的主要企業。這些因素為新診斷方法的快速發展和廣泛應用創造了有利環境。在歐洲，德國、英國和法國發揮關鍵作用。這些國家受益於先進的醫療保健體系，該體系促進了高品質的醫療保健，並持續進行研發活動，旨在提高診斷準確性並開發新的檢測方案。同時，中國和印度已成為高成長市場，這得益於其龐大的患者群體和不斷擴展的診斷網路，從而提高了基本服務的可及性。此外，兩國越來越重視疾病的早期檢測，這與全球預防性醫療保健的趨勢相符。這些因素共同作用，使這兩個國家在診斷領域擁有加速成長的優勢，並有助於改善阿茲海默症患者的治療效果。

目錄

第1章阿茲海默症診斷市場概覽

  • 調查範圍
  • 市場預測期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章阿茲海默症診斷的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章阿茲海默症診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 法規結構分析

第5章阿茲海默症診斷市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章阿茲海默症診斷市場概況

  • 2024年阿茲海默症診斷市佔率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章阿茲海默症診斷市場（按類型分類）

  • 概述
    • 細分市場佔有率分析：按類型
    • 早發性阿茲海默症
    • 晚發性阿茲海默症
    • 其他

第8章阿茲海默症診斷市場（按診斷技術分類）

  • 概述
    • 依診斷技術進行細分市場佔有率分析
    • 神經影像學
    • 生物標記檢測
    • 基因檢測
    • 認知功能測試
    • 其他

第9章阿茲海默症診斷市場（按最終用戶分類）

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院和診所
    • 診斷檢查室
    • 研究所
    • 其他

第10章阿茲海默症診斷市場（按地區分類）

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析—阿茲海默症診斷產業

  • 競爭對手儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • GE HealthCare
    • Fujirebio
    • Biogen
    • Quanterix
    • C2N Diagnostics
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Others

第12章：分析師視角

簡介目錄
Product Code: ANV5952

The Alzheimer's disease Diagnostics Market size was valued at US$ 9,2190.10 Million in 2024, expanding at a CAGR of 11.19% from 2025 to 2032.

The global Alzheimer's disease diagnostics market is witnessing steady growth due to the rising prevalence of neurodegenerative disorders, the increasing ageing population, and growing awareness regarding early diagnosis. Technological advancements in biomarker-based testing, neuroimaging, and blood-based diagnostics are improving detection accuracy and enabling earlier intervention. Supportive government initiatives, increased research funding, and expanding access to diagnostic services are further contributing to market growth across both developed and emerging economies.

Alzheimer's Disease Diagnostics Market- Market Dynamics

Rising prevalence of Alzheimer's disease and an ageing population

The increasing global geriatric population and the rising incidence of Alzheimer's disease are key drivers fueling demand for advanced diagnostic solutions. Early and accurate diagnosis is essential for effective disease management, timely treatment planning, and improving patient quality of life. For instance, in January 2025, the European Brain Council reported that nearly 7 million people across Europe are currently living with Alzheimer's disease, and with an ageing population, this number is projected to rise to approximately 14 million by 2030, highlighting the growing public health burden of the disease. Advancements in diagnostic technologies, including biomarker-based assays and non-invasive neuroimaging techniques, combined with increasing awareness among healthcare professionals, are accelerating diagnostic adoption. In parallel, continuous R&D investments by diagnostic companies are strengthening product pipelines and expanding global diagnostic capabilities.

Alzheimer's disease Diagnostics Market- Segmentation Analysis:

The Global Alzheimer's Disease Diagnostics Market is segmented on the basis of Type, Diagnostic Technique, End User, and Region.

Based on Type, the market is categorised into Early-Onset Alzheimer's Disease and Late-Onset Alzheimer's Disease. Late-onset Alzheimer's disease holds a dominant share due to its higher prevalence among the elderly population. Additionally, the rising global geriatric population and increased life expectancy significantly contribute to the growing number of late-onset cases. Improved diagnostic awareness and higher healthcare utilisation among older adults further reinforce the dominance of this segment in the market.

Based on the diagnostic technique, the market is categorised into Neuroimaging, Biomarker Tests, Genetic Testing, Cognitive Tests, and Others. Neuroimaging and biomarker-based diagnostics account for a significant share owing to their high diagnostic accuracy and growing clinical adoption. Advancements in imaging technologies and biomarker discovery have enabled earlier and more reliable detection of Alzheimer's disease. Furthermore, increasing investments in precision medicine and the integration of these techniques into clinical trials are driving their widespread use..

Based on End User, the market is categorised into Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, and Others. Hospitals and diagnostic laboratories dominate due to high patient inflow and access to advanced diagnostic infrastructure. These settings also benefit from the availability of skilled healthcare professionals and integrated diagnostic services, enabling timely and accurate disease detection. Additionally, rising hospital-based screening programs and referrals further strengthen their market dominance.

Alzheimer's Disease Diagnostics Market- Geographical Insights

North America holds the leading position in the Alzheimer's disease diagnostics market, attributed to its advanced healthcare infrastructure, high levels of public awareness, and rapid adoption of innovative diagnostic technologies. These factors facilitate early detection and timely intervention, which are crucial in managing Alzheimer's disease effectively. Europe follows closely, bolstered by well-established research facilities and supportive government healthcare policies that encourage investment in new diagnostic methodologies and technologies. In the Asia-Pacific region, anticipated rapid growth is driven by a significantly ageing population, coupled with improving healthcare access and increasing investments in diagnostic infrastructure, particularly in major markets like China and India. These nations are prioritising the enhancement of their healthcare systems to address the rising prevalence of Alzheimer's. Meanwhile, Latin America and the Middle East & Africa are experiencing gradual growth as public awareness around Alzheimer's improves, alongside advancements in diagnostic capabilities, ultimately contributing to better patient management and outcomes in these regions.

Alzheimer's Disease Diagnostics Market- Country Insights

The United States maintains a dominant position in the Alzheimer's disease diagnostics market, attributable to its high utilisation of diagnostic tests, robust reimbursement frameworks that facilitate patient access to cutting-edge technologies, and the presence of leading diagnostic companies driving innovation. These factors create a conducive environment for the rapid development and adoption of new diagnostic methods. In Europe, Germany, the UK, and France play significant roles, benefiting from their advanced healthcare systems that promote high-quality care and ongoing research activities aimed at enhancing diagnostic accuracy and developing novel testing solutions. Meanwhile, China and India are emerging as high-growth markets, fueled by their large patient populations and expanding diagnostic networks that enhance accessibility to essential services. Additionally, both countries are increasingly focusing on early disease detection, aligning with global trends that emphasize proactive healthcare measures. This combination of factors positions them favorably for accelerated growth in the diagnostic landscape, contributing to improving outcomes for patients with Alzheimer's disease.

Alzheimer's disease Diagnostics Market- Competitive Landscape:

The Alzheimer's disease diagnostics market is moderately competitive, with key players prioritizing technological innovation, biomarker development, and strategic collaborations to strengthen their market presence. For instance, August 2025: BGI Genomics developed an in-house blood-based diagnostic test for Alzheimer's disease and other cognitive disorders, following China's national regulatory approval received in April 2024. The test analyses five key blood-based biomarkers, including specific tau and amyloid protein variants, as well as additional neuro-related indicators, providing clinicians with a more comprehensive understanding of underlying brain pathology. Furthermore, ongoing clinical trials for investigational diagnostic tools and novel biomarkers continue to support innovation and are significantly accelerating overall market growth. Companies are increasingly investing in advanced blood-based tests, imaging solutions, and AI-enabled diagnostic tools aimed at improving early detection and clinical outcomes. Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers are prominent leaders in this space, leveraging their extensive research capabilities to develop cutting-edge diagnostic technologies. GE HealthCare and Fujirebio specialise in advanced imaging techniques and biomarker assays, further advancing diagnostic accuracy. Additionally, Biogen and Quanterix focus on innovative therapies and diagnostic solutions to address the complexities of Alzheimer's. C2N Diagnostics, Thermo Fisher Scientific, and Danaher Corporation also contribute significantly, providing specialized tools and technologies for early detection. Together, these companies shape a dynamic landscape that is critical for enhancing understanding and management of Alzheimer's disease through improved diagnostic capabilities.

Recent Developments:

On May 16, 2025, the FDA cleared the first in vitro blood test to aid in the diagnosis of Alzheimer's disease. Developed by Fujirebio Diagnostics, Inc., the Lumipulse G pTau217 / B-Amyloid 1-42 Plasma Ratio is designed to detect amyloid plaques in adults aged 55 and older who exhibit symptoms of cognitive impairment.

In August 2025, C2N Diagnostics, LLC announced a major global expansion of its PrecivityAD2 blood test, reaching additional healthcare providers across Asia, Europe, Latin America, and the Middle East. This initiative aims to broaden access to high-precision Alzheimer's disease diagnostics, particularly in regions with limited imaging infrastructure.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • GE HealthCare
  • Fujirebio
  • Biogen
  • Quanterix
  • C2N Diagnostics
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Early-Onset Alzheimer's Disease
  • Late-Onset Alzheimer's Disease
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TECHNIQUE ANALYSIS, 2019 - 2032

  • Neuroimaging
  • Biomarker Tests
  • Genetic Testing
  • Cognitive Tests
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Alzheimer's Disease Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Alzheimer's Disease Diagnostics Market Snippet by Type
    • 2.1.2. Alzheimer's Disease Diagnostics Market Snippet by Diagnostic Technique
    • 2.1.3. Alzheimer's Disease Diagnostics Market Snippet by End User
    • 2.1.4. Alzheimer's Disease Diagnostics Market Snippet by Country
    • 2.1.5. Alzheimer's Disease Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Alzheimer's Disease Diagnostics Key Market Trends

  • 3.1. Alzheimer's Disease Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Alzheimer's Disease Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Alzheimer's Disease Diagnostics Market Opportunities
  • 3.4. Alzheimer's Disease Diagnostics Market Future Trends

4. Alzheimer's Disease Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Alzheimer's Disease Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Alzheimer's Disease Diagnostics Market Landscape

  • 6.1. Alzheimer's Disease Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Alzheimer's Disease Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Early-Onset Alzheimer's Disease
    • 7.1.3. Late-Onset Alzheimer's Disease
    • 7.1.4. Others

8. Alzheimer's Disease Diagnostics Market - By Diagnostic Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnostic Technique, 2024&2032 (%)
    • 8.1.2. Neuroimaging
    • 8.1.3. Biomarker Tests
    • 8.1.4. Genetic Testing
    • 8.1.5. Cognitive Tests
    • 8.1.6. Others

9. Alzheimer's Disease Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Others

10. Alzheimer's Disease Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Alzheimer's Disease Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Alzheimer's Disease Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Alzheimer's Disease Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Alzheimer's Disease Diagnostics Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Alzheimer's Disease DiagnosticsKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Alzheimer's Disease Diagnostics Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Siemens Healthineers
    • 11.2.4. GE HealthCare
    • 11.2.5. Fujirebio
    • 11.2.6. Biogen
    • 11.2.7. Quanterix
    • 11.2.8. C2N Diagnostics
    • 11.2.9. Thermo Fisher Scientific
    • 11.2.10. Danaher Corporation
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us